Summary
PMGC Holdings Inc. (NASDAQ:ELAB) experienced a 6.5% premarket share increase after its subsidiary, NorthStrive Defense Tech, executed a binding term sheet to obtain exclusive commercial rights to a patented multi-domain drone technology. The arrangement includes a sponsored research program to test and refine the underlying mechanics of cable-suspended payload transport across air and water.
Deal terms and scope
The binding term sheet provides NorthStrive Defense Tech exclusive, worldwide, sublicensable commercial rights to U.S. Patent No. 12,291,334 within the aerospace and defense field. The licensed patent covers a method that enables an aerial vehicle to autonomously carry a cable-suspended payload across both air and water by using buoyancy-assisted transport.
The license applies for the life of the patent and authorizes NorthStrive Defense Tech to develop, manufacture, market, sell, and distribute licensed products in the aerospace and defense technologies sector. The binding term sheet follows an earlier exclusive option arrangement that was announced on April 6.
Sponsored research program
In parallel with the licensing term sheet, NorthStrive Defense Tech has entered a 12-month sponsored research agreement scheduled to run from June 2026 through June 2027. The stated objective of the research program is to validate trajectory control and hydrodynamic stability for cable-suspended payloads. Work under the program will include the design and fabrication of a small-payload prototype and empirical testing of towing dynamics.
Specified research milestones include the completion of conceptual and mechanical designs, fabrication of prototype hardware, and hands-on empirical testing, culminating in a final written research report. The agreement specifies that any new inventions that arise from the sponsored research will be owned by the licensor; however, NorthStrive Defense Tech will receive a first option to negotiate a royalty-bearing commercial license for such inventions.
Corporate intent and cautions
PMGC Holdings noted that it cannot provide assurances regarding the commercial success of the patented technology. The company said it plans to continue evaluating additional avenues to grow its portfolio in aerospace, defense, autonomous systems, and dual-use technologies, using tools such as licensing, acquisition, sponsored research, and strategic collaborations.
Market reaction
Following the announcements related to the exclusive license and the sponsored research agreement, PMGC Holdings shares rose 6.5% in premarket trading on Monday.